Shares of Twist Bioscience jumped nearly 10% in Wednesday morning trading after the company forged an agreement with Takeda Pharmaceutical to expand biologics discovery capabilities and discover, validate and optimize new antibody candidates for a number of different indications.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,